2 results
Approved WMOCompleted
The aim of this study is to assess for the first time in humans, the safety and feasibility of the EndoRotor® for the ablation of Barrett*s esophagus.
Approved WMOCompleted
The primary objective of this study is to assess the objective response rates (ORR) for two starting doses of vandetanib, 150 mg and 300 mg in patients with unresectable locally advanced or metastatic MTC having progressive or symptomatic disease.…